Collectively, our data suggest that BET inhibition may be combined with Aurora Kinase A inhibition to increase the efficacy of monotherapy, especially in cases where BET inhibition lacks a substantial effect on tumor cells. The gene discussed is DNER; the disease is neoplasm.